Cedric Francois - Dec 31, 2021 Form 5 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Executive Officer, Director
Signature: /s/ David Watson, attorney-in-fact for Cedric Francois
Stock symbol: APLS
Transactions as of: Dec 31, 2021
Transactions value $: $0
Form type: 5
Date filed: 2/10/2022, 03:47 PM
Previous filing: Jul 22, 2021
Next filing: Jan 25, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Gift	$0	-80K	-8.56%	$0.00	854K	Jun 16, 2021	Direct
holding	APLS	Common Stock						234K	Dec 31, 2021	See footnote	F1
holding	APLS	Common Stock						300K	Dec 31, 2021	See footnote	F2

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F2	The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.